Stefan Kinner

Stefan Kinner currently serves as the Director of Government Affairs & Public Policy for Vertex Pharmaceuticals in Germany, where he plays a pivotal role in shaping the company’s strategic engagement with policymakers, healthcare stakeholders, and industry partners across Europe’s largest pharmaceutical market. With over 13 years of professional experience spanning three global leaders in Pharma and Biotech, Stefan brings a wealth of expertise in government affairs, market access, and corporate communication, particularly within the DACH region and broader Central and Eastern European markets. His deep understanding of the German healthcare landscape has been instrumental in navigating complex regulatory environments, including AMNOG-related communication and policy initiatives from the very inception of Vertex’s operations in Germany.

In his current role, Stefan leads efforts to advocate for innovative therapies, with a strong focus on rare diseases and advanced therapy medicinal products (ATMPs), especially gene therapies. His strategic approach combines stakeholder management, political engagement, and policy development to ensure favorable access pathways and sustainable market conditions for Vertex’s groundbreaking treatments. As a member of the German core leadership team, he collaborates closely with cross-functional partners to align public policy strategies with corporate objectives, fostering trust and transparency with health authorities, patient organizations, and industry peers.

Stefan’s expertise extends to managing high-level communications around market access and policy issues, leveraging his skills in corporate communications and corporate social responsibility. His robust network within German health politics and his strategic insights into the political landscape make him a key influencer in shaping the future of innovative biotech therapies in Europe. His leadership continues to advance Vertex’s mission to transform lives through pioneering medicines, while ensuring a proactive and compliant engagement with the evolving healthcare environment.